We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -1.11% | 2.225 | 2.15 | 2.30 | 2.25 | 2.05 | 2.25 | 5,550,774 | 09:12:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.34 | 12.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2024 07:05 | Morning Alex. | socionomics | |
31/7/2024 07:04 | Amazing utter Bargin below 2p still have some at 10p but looking awesome here 20p soon enough :D | g2theary | |
31/7/2024 07:02 | The amount people are having to pay? Over 5. | hazl | |
31/7/2024 06:59 | This will be in play throughout the day in my opinion. This is big news! | hazl | |
31/7/2024 06:58 | RUN FOR THE HILLS!! | purple11 | |
31/7/2024 06:58 | Lovely. Finally someone more repulsive than Z1co. At least you are only here for a day, max. | premium beeks | |
31/7/2024 06:58 | Whilst positioned primarily for enabling near-patient testing, the Genedrive® System is also suitable for traditional laboratory testing paradigms as a more affordable alternative to laboratory platforms where sample throughput requirements do not necessitate high-scale batch processing. | hazl | |
31/7/2024 06:57 | Firey 9.11 please | countbasie1 | |
31/7/2024 06:57 | First buy of the day @ 4.70p!!! | z1co | |
31/7/2024 06:56 | Zen12 They are a sad bunch of LOSERS | z1co | |
31/7/2024 06:56 | Meanwhile you don't think all those involved in the placing won't be selling on todays spike? Along with the resident bonehead? | premium beeks | |
31/7/2024 06:56 | Today at last! | hazl | |
31/7/2024 06:54 | Like I say, outside the headline that was already known, the rest of it tells me the company will need a load more cash to get this through to profitability. The committee acknowledged that implementing laboratory-based testing for everyone who has a stroke or TIA could be done in a stepwise process. This would involve a gradual increase in numbers tested while capacity is established. Testing could be initially started in groups of people who could benefit most from it, because of higher risk of stroke recurrence, such as people with non‑minor stroke. Alternatively, point-of-care testing should be considered as an alternative if laboratory-based testing is not feasible at this scale, or while capacity for laboratory-based testing is increased. See section 3.21 for further discussion of these issues. | premium beeks | |
31/7/2024 06:54 | Deramperz already working overtime and it's not even 8 yet...! | zen12 | |
31/7/2024 06:49 | 4.5-4.6p pre market is a slap in the face on this news, is it not? | divmad | |
31/7/2024 06:48 | READ IT AGAIN OLD MAN The Company will now actively pursue commercialisation in the UK and Middle Eastern countries where device registration is enabled by UKCA certification, and is fully prepared to supply and meet the anticipated demand. | z1co | |
31/7/2024 06:47 | HEY CLOWN it's 4.60p to buy , get some at the open and make some money. | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions